| View |
|
BR-673
|
Recombinant Human Thrombopoietin
|
Tpiao
|
15,000 IU/mL
|
Solution for Injection (S.C.)
|
Prescription Drug (Rx)
|
Single dose. Glass vial x 1mL (Box of 1's).
|
Colony-Stimulating Factors
|
Shenyang Sunshine Pharamceutical Co., Ltd.
|
China
|
N/A
|
Goodfellow Pharma Corporation
|
Goodfellow Pharma Corporation
|
Automatic Renewal
|
23 September 2022
|
23 September 2027
|
| View |
|
BR-674
|
Live Attenuated Rotavirus Vaccine
|
Rotarix
|
NLT 106.0 CCID 50/1.5 mL
|
Oral Suspension
|
Prescription Drug (RX)
|
Pre-filled glass syringe x 1.5 mL (Box of l's, 10's and
50's)
|
-
|
GlaxoSmithKline Biologicals S.A.
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
|
Renewal
|
15 September 2022
|
13 August 2027
|
| View |
|
BR-675
|
Recombinant Hepatitis B Vaccine
|
Amvax-B
|
20 mcg/mL
|
Suspension For Injection (IM)
|
Prescription Drug (RX)
|
1mL Glass Ampoule (Box of 1's)
|
Vaccine
|
Amson Vaccines & Pharma (Pvt.) Ltd
|
Pakistan
|
N/A
|
Sahar International Trading, Inc.
|
N/A
|
Renewal
|
29 January 2024
|
06 March 2029
|
| View |
|
BR-676
|
Anti-Rabies Serum (Equine)
|
Equirab
|
200 IU/ mL (1,000 IU/ 5mL)
|
Solution for Injection (IM/SC)
|
Prescription Drug (Rx)
|
USP Type I Glass vial x 5mL (Box of 1's)
|
-
|
Bharat Serums and Vaccines Limited
|
India
|
|
NEW MARKETLINK PHARMACEUTICAL CORPORATION
|
NEW MARKETLINK PHARMACEUTICAL CORPORATION
|
-
|
30 March 2021
|
06 March 2026
|
| View |
|
BR-680
|
HEPATITIS B VACCINE (RECOMBINANT DNA )
|
Unbranded
|
20mcg/mL
|
Suspension For Injection (IM)
|
Prescription Drug (RX)
|
Type I clear glass ampoule x 1mL (Box of 1's, 10's and 50's). Single dose.
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
|
Genpharm Inc.
|
Genpharm Inc.
|
Renewal
|
01 March 2024
|
01 June 2029
|
| View |
|
BR-685
|
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
|
Synflorix
|
Each 0.5 mL dose contains:
1 mcg of polysaccharide for serotypes 1 1,2, 5 1,2, 6B 1,2, 7F1.2, 9V 1,2, 14 1,2 and 23F 1,2 and 3 mcg of serotypes 4 1,2, 18C 1,3, and 19F 1,4
'Adsorbed on aluminium phosphate 500 mcg A 13+ 2Conjugate to protein D (derived from Non-Typeable Haemophilus influenzae) carrier protein eq. to 9-16 mcg
3Conjugate to tetanus toxoid carrier protein eq. to 5-10 mcg
4Conjugate to diphtheria toxoid carrier protein e.q. to 3-6 mcg
|
Suspension for Injection (IM)
|
Prescription Drug (RX)
|
0.5mL prefilled syringe (Type I) with a plunger stopper (Rubber butyl) + 1 needle box in a plastic blister tray of 1 (Box of 1's)
|
Pneumococcal Vaccine
|
GlaxoSmithKline Biologicals S.A.
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
Renewal
|
25 July 2024
|
26 June 2029
|
| View |
BR-689_PI_01.pdf
|
BR-689
|
Tocilizumab
|
Actemra
|
400 mg/ 20 mL
|
Concentrate For Solution For I.V. Infusion
|
Prescription Drug (RX)
|
20 mL colorless Type I glass vial per box
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
10 April 2023
|
20 March 2028
|
| View |
BR-690_PI_01.pdf
|
BR-690
|
Tocilizumab
|
Actemra
|
80 mg/ 4 mL
|
Concentrate For Solution For I.V. Infusion
|
Prescription Drug (RX)
|
20 mL colorless Type I glass vial per box
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
14 April 2023
|
20 March 2028
|
| View |
BR-691_PI_01.pdf
|
BR-691
|
Tocilizumab
|
Actemra
|
200 mg / 10 mL
|
Concentrate For Solution For I.V. Infusion
|
Prescription Drug (RX)
|
20 mL colorless Type I glass vial per box
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
09 April 2023
|
20 March 2028
|
| View |
|
BR-698
|
Filgrastim
|
Recombicyte
|
300mg/0.9mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (RX)
|
0.9 m L Pre-filled Syringe (Box of 1's)
|
-
|
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
|
China
|
N/A
|
Global Pharmatrade
|
Global Pharmatrade
|
Renewal
|
27 April 2021
|
01 July 2026
|
| View |
|
BR-701
|
Epoetin Alfa
|
Eprex
|
4000 IU/0.4 mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
0.4 mL Solution in a Type I pre-filled glass syringe
fitted with PROTECSTM needle guard (Box of l's)
|
-
|
Cilag AG
|
Switzerland
|
N/A
|
Johnson & Johnson (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
04 February 2022
|
29 July 2026
|
| View |
|
BR-702
|
Epoetin Alfa
|
Eprex
|
10000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL Solution in a Type I pre-filled glass syringe
fitted with PROTECSTM needle guard (Box of l’s)
|
-
|
Cilag AG
|
Switzerland
|
N/A
|
Johnson & Johnson (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
04 February 2022
|
29 July 2026
|
| View |
|
BR-704
|
Epoetin Alfa
|
Eprex
|
40000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL Solution in a Type I pre-filled glass syringe
fitted with PROTECSTM needle guard (Box of l’s)
|
-
|
Cilag AG
|
Switzerland
|
N/A
|
Johnson & Johnson (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
04 February 2022
|
29 July 2026
|
| View |
|
BR-709
|
Human Antitetanus Immunoglobulin
|
Igantet
|
500 IU/2 mL
|
Solution for Injection (IM
|
Prescription Drug (RX)
|
2 mL Type I Glass Pre-filled Syringe (Box of 1's)
|
Immunoglobulin
|
Instituto Grifols, S. A.
|
Spain
|
|
GB Distributors, Inc.
|
GB Distributors, Inc.
|
Regular Renewal
|
19 March 2021
|
07 January 2025
|
| View |
|
BR-710
|
Human Antitetanus Immunoglobulin
|
Igantet
|
250 IU/mL
|
Solution for Injection (IM)
|
Prescription Drug (RX)
|
1 mL Type I Glass Pre-filled Syringe (Box of 1's)
|
Immunoglobulin
|
Instituto Grifols, S. A.
|
Spain
|
|
GB Distributors, Inc.
|
GB Distributors, Inc.
|
Renewal (Correction)
|
15 July 2021
|
07 January 2025
|
| View |
|
BR-713
|
Recombinant Human Erythropoietin Alfa
|
Efotin
|
4000 IU/0.8mL
|
Solution For IV Injection
|
Prescription Drug (RX)
|
Type I Glass Pre-filled Syringe (Net content: 0.8 mL) (Box of 1's)
|
-
|
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
|
China
|
N/A
|
Global Pharmatrade
|
Global Pharmatrade
|
-
|
21 April 2021
|
11 February 2026
|
| View |
|
BR-714
|
Hepatitis B Vaccine (rDNA)
|
Euvax B (Adult) - Preservative Free
|
20 mcg/mL
|
Suspension For Injection (IM)
|
Prescription Drug (RX)
|
Single dose. Type I glass vial x 1 mL (Box of 1's)
|
-
|
LG Chem, Ltd.
|
Korea
|
N/A
|
Sanofi Pasteur, Inc.
|
Zuellig Pharma Corporation
|
-
|
19 January 2022
|
15 February 2025
|
| View |
|
BR-715
|
Hepatitis B Vaccine (rDNA)
|
Euvax B (Pediatric) - Preservative Free
|
10 mcg/0.5 mL
|
Suspension For Injection (IM)
|
Prescription Drug (RX)
|
Single dose. Type I glass vial x 0.5 mL (Box of 1's)
|
-
|
LG Chem, Ltd.
|
Korea
|
N/A
|
Sanofi Pasteur, Inc.
|
Zuellig Pharma Corporation
|
-
|
19 January 2022
|
15 February 2025
|
| View |
|
BR-718
|
Imiglucerase
|
Cerezyme
|
400 U
|
Powder for Concentrate for Solution for Infusion.
(IV)
|
Prescription Drug (Rx)
|
20 mL clear, colorless Type I glass vial (Box of 1's). For single use only.
|
Enzymes
|
Genzyme Ireland Limited
|
Ireland
|
|
Sanofi-Aventis Philippines, Inc.
|
Sanofi-Aventis Philippines, Inc.
|
Renewal
|
12 August 2024
|
10 June 2029
|
| View |
|
BR-724
|
Hepatitis B Vaccine (rDNA)
|
Revac-B+
|
20 mcg/mL
|
Solution For Injection (IM)
|
Prescription Drug (RX)
|
1 mL Type I glass vial (Box of 1's). Single adult dose
|
-
|
Bharat Biotech International Ltd.
|
India
|
|
ULIVaccines, Inc.
|
ULIVaccines, Inc.
|
-
|
08 March 2021
|
14 April 2025
|